Published in J Virol on February 01, 1998
Genome-wide analysis of vaccinia virus protein-protein interactions. Proc Natl Acad Sci U S A (2000) 2.81
Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells. J Virol (1999) 2.43
Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles. J Virol (2006) 2.38
Elucidating the essential role of the A14 phosphoprotein in vaccinia virus morphogenesis: construction and characterization of a tetracycline-inducible recombinant. J Virol (2000) 2.20
Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene. J Virol (2004) 2.06
Endoplasmic reticulum-Golgi intermediate compartment membranes and vimentin filaments participate in vaccinia virus assembly. J Virol (2002) 1.94
Vaccinia virus A21 virion membrane protein is required for cell entry and fusion. J Virol (2005) 1.86
The genome of Melanoplus sanguinipes entomopoxvirus. J Virol (1999) 1.84
Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC. J Virol (2007) 1.68
Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: isolation of a dominant, temperature-sensitive mutant with a profound defect in morphogenesis. J Virol (2000) 1.50
Tyrosine phosphorylation of A17 during vaccinia virus infection: involvement of the H1 phosphatase and the F10 kinase. J Virol (1999) 1.48
Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein. J Virol (2006) 1.45
Vaccinia virus G7L protein Interacts with the A30L protein and is required for association of viral membranes with dense viroplasm to form immature virions. J Virol (2003) 1.39
Vaccinia virus nonstructural protein encoded by the A11R gene is required for formation of the virion membrane. J Virol (2005) 1.39
Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene. J Virol (2006) 1.35
Activation of the PI3K/Akt pathway early during vaccinia and cowpox virus infections is required for both host survival and viral replication. J Virol (2009) 1.30
Vaccinia virus A30L protein is required for association of viral membranes with dense viroplasm to form immature virions. J Virol (2001) 1.29
Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells. J Virol (2006) 1.26
Investigation of structural and functional motifs within the vaccinia virus A14 phosphoprotein, an essential component of the virion membrane. J Virol (2003) 1.26
Cell biological and functional characterization of the vaccinia virus F10 kinase: implications for the mechanism of virion morphogenesis. J Virol (2005) 1.25
Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid rafts. J Virol (2005) 1.23
Existence of an operative pathway from the endoplasmic reticulum to the immature poxvirus membrane. Proc Natl Acad Sci U S A (2006) 1.23
The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis. J Virol (2000) 1.16
Assembly and disassembly of the capsid-like external scaffold of immature virions during vaccinia virus morphogenesis. J Virol (2009) 1.14
Evidence for an essential catalytic role of the F10 protein kinase in vaccinia virus morphogenesis. J Virol (2004) 1.13
Genetic and cell biological characterization of the vaccinia virus A30 and G7 phosphoproteins. J Virol (2005) 1.09
Physical and functional interactions between vaccinia virus F10 protein kinase and virion assembly proteins A30 and G7. J Virol (2004) 1.08
Vaccinia virus J1R protein: a viral membrane protein that is essential for virion morphogenesis. J Virol (2002) 1.08
The major core protein P4a (A10L gene) of vaccinia virus is essential for correct assembly of viral DNA into the nucleoprotein complex to form immature viral particles. J Virol (2001) 1.07
Vaccinia virus morphogenesis: a13 phosphoprotein is required for assembly of mature virions. J Virol (2004) 1.07
Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication. J Virol (2000) 1.05
The block in assembly of modified vaccinia virus Ankara in HeLa cells reveals new insights into vaccinia virus morphogenesis. J Virol (2002) 1.04
Vaccinia virus H7 protein contributes to the formation of crescent membrane precursors of immature virions. J Virol (2009) 1.04
African swine fever virus structural protein p54 is essential for the recruitment of envelope precursors to assembly sites. J Virol (2004) 1.02
Vaccinia virus mutants with alanine substitutions in the conserved G5R gene fail to initiate morphogenesis at the nonpermissive temperature. J Virol (2004) 1.02
Participation of vaccinia virus l2 protein in the formation of crescent membranes and immature virions. J Virol (2011) 1.00
Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells. J Virol (2003) 1.00
Biogenesis of the vaccinia virus membrane: genetic and ultrastructural analysis of the contributions of the A14 and A17 proteins. J Virol (2012) 0.94
Disulfide bonds and membrane topology of the vaccinia virus A17L envelope protein. J Virol (2000) 0.93
Vaccinia virus A6 is essential for virion membrane biogenesis and localization of virion membrane proteins to sites of virion assembly. J Virol (2012) 0.93
Vaccinia virus virion membrane biogenesis protein A11 associates with viral membranes in a manner that requires the expression of another membrane biogenesis protein, A6. J Virol (2012) 0.91
Analysis of viral membranes formed in cells infected by a vaccinia virus L2-deletion mutant suggests their origin from the endoplasmic reticulum. J Virol (2012) 0.90
Poxvirus membrane biogenesis. Virology (2015) 0.89
Association of the vaccinia virus A11 protein with the endoplasmic reticulum and crescent precursors of immature virions. J Virol (2013) 0.89
Lipid membranes in poxvirus replication. Viruses (2010) 0.88
Analysis of the role of vaccinia virus H7 in virion membrane biogenesis with an H7-deletion mutant. J Virol (2013) 0.85
Effects of a temperature sensitivity mutation in the J1R protein component of a complex required for vaccinia virus assembly. J Virol (2005) 0.82
Viral miniproteins. Annu Rev Microbiol (2014) 0.82
The E6 protein from vaccinia virus is required for the formation of immature virions. Virology (2010) 0.81
From crescent to mature virion: vaccinia virus assembly and maturation. Viruses (2014) 0.81
Vaccinia virus A12L protein and its AG/A proteolysis play an important role in viral morphogenic transition. Virol J (2007) 0.79
Poxviruses Encode a Reticulon-Like Protein that Promotes Membrane Curvature. Cell Rep (2016) 0.76
Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol (1994) 4.67
Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks. J Cell Biol (1993) 4.34
The development of vaccinia virus in Earle's L strain cells as examined by electron microscopy. J Biophys Biochem Cytol (1961) 4.32
Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein. J Virol (1991) 3.79
Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination. Virology (1971) 3.57
Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment. J Virol (1985) 3.44
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus. J Virol (1985) 3.06
Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes. J Virol (1970) 3.00
Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Virology (1994) 2.89
Polypeptide composition of extracellular enveloped vaccinia virus. J Virol (1978) 2.79
Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis. J Virol (1996) 2.77
Transfer of the inducible lac repressor/operator system from Escherichia coli to a vaccinia virus expression vector. Proc Natl Acad Sci U S A (1989) 2.67
The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology (1993) 2.66
Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J Virol (1993) 2.64
Letter: Protein cleavage and poxvirus morphogenesis: tryptic peptide analysis of core precursors accumulated by blocking assembly with rifampicin. J Mol Biol (1973) 2.47
Biogenesis of vaccinia: separation of early stages from maturation by means of rifampicin. Virology (1970) 2.44
IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. Nucleic Acids Res (1990) 2.41
Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. J Virol (1992) 2.35
Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65. J Virol (1994) 2.17
Immature viral envelope formation is interrupted at the same stage by lac operator-mediated repression of the vaccinia virus D13L gene and by the drug rifampicin. Virology (1992) 2.07
Conditional lethal expression of the vaccinia virus L1R myristylated protein reveals a role in virion assembly. J Virol (1994) 2.04
Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J Virol (1996) 2.01
Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein. J Virol (1997) 2.00
A mutation in the gene encoding the vaccinia virus 37,000-M(r) protein confers resistance to an inhibitor of virus envelopment and release. J Virol (1991) 1.90
Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis. J Virol (1995) 1.89
Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein. J Virol (1987) 1.87
Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. J Virol (1992) 1.86
The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene. J Virol (1993) 1.86
Temperature-sensitive mutants with lesions in the vaccinia virus F10 kinase undergo arrest at the earliest stage of virion morphogenesis. J Virol (1995) 1.85
The role of a 21-kDa viral membrane protein in the assembly of vaccinia virus from the intermediate compartment. J Biol Chem (1996) 1.79
Vaccinia virus gene D8 encodes a virion transmembrane protein. J Virol (1988) 1.78
Inducible gene expression from vaccinia virus vectors. Virology (1990) 1.76
Vaccinia virus morphogenesis is interrupted when expression of the gene encoding an 11-kilodalton phosphorylated protein is prevented by the Escherichia coli lac repressor. J Virol (1991) 1.74
N-terminal amino acid sequences of vaccinia virus structural proteins. Virology (1994) 1.71
Vaccinia virus morphogenesis is blocked by temperature-sensitive mutations in the F10 gene, which encodes protein kinase 2. J Virol (1995) 1.62
Vaccinia virus membrane proteins p8 and p16 are cotranslationally inserted into the rough endoplasmic reticulum and retained in the intermediate compartment. J Virol (1997) 1.60
Characterization of vaccinia virus glycoproteins by monoclonal antibody precipitation. Virology (1992) 1.56
Structural and functional characterization of a cell surface binding protein of vaccinia virus. J Biol Chem (1990) 1.54
Characterization of the vaccinia virus L1R myristylprotein as a component of the intracellular virion envelope. J Gen Virol (1994) 1.39
A vaccinia virus core protein, p39, is membrane associated. J Virol (1996) 1.37
Biogenesis of vaccinia: concerning the origin of the envelope phospholipids. Virology (1974) 1.29
Physical mapping and DNA sequence analysis of the rifampicin resistance locus in vaccinia virus. Virology (1985) 1.22
Vaccinia virus core protein VP8 is required for virus infectivity, but not for core protein processing or for INV and EEV formation. Virology (1994) 1.20
Inducible expression of the vaccinia virus A17L gene provides a synchronized system to monitor sorting of viral proteins during morphogenesis. J Virol (1996) 1.20
Insertional inactivation of the vaccinia virus 32-kilodalton gene is associated with attenuation in mice and reduction of viral gene expression in polarized epithelial cells. J Virol (1992) 1.10
Mutations in ORF D13L and other genetic loci alter the rifampicin phenotype of vaccinia virus. Virology (1993) 1.06
Use of a cell-free system to identify the vaccinia virus L1R gene product as the major late myristylated virion protein M25. J Virol (1990) 1.05
Isolation and analysis of vaccinia virus previrions. Virus Genes (1993) 0.96
Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev (2006) 4.13
The dsRNA protein kinase PKR: virus and cell control. Biochimie (2007) 3.67
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus. J Virol (1985) 3.06
Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J Immunol Methods (1995) 2.82
The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology (1994) 2.78
Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis (2000) 2.63
A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. J Virol (1987) 2.53
Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci U S A (1993) 2.44
Bacteriophage capsids: tough nanoshells with complex elastic properties. Proc Natl Acad Sci U S A (2004) 2.30
Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein. Virology (1990) 2.27
Structure of viral connectors and their function in bacteriophage assembly and DNA packaging. Q Rev Biophys (1994) 2.24
Bacillus subtilis phage phi29. Characterization of gene products and functions. Eur J Biochem (1976) 2.17
Deubiquitinases in cancer: new functions and therapeutic options. Oncogene (2011) 2.08
Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system. Virology (1984) 2.04
Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein. J Virol (1997) 2.00
Eukaryotic type II chaperonin CCT interacts with actin through specific subunits. Nature (1999) 1.93
Sharpening high resolution information in single particle electron cryomicroscopy. J Struct Biol (2008) 1.93
Analysis of electron microscope images and electron diffraction patterns of thin crystals of phi 29 connectors in ice. J Mol Biol (1994) 1.90
Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis. J Virol (1995) 1.89
Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein. J Virol (1987) 1.87
Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. J Virol (1992) 1.86
The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene. J Virol (1993) 1.86
Ultrastructural and functional analyses of recombinant influenza virus ribonucleoproteins suggest dimerization of nucleoprotein during virus amplification. J Virol (2000) 1.86
Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals. Proc Natl Acad Sci U S A (1988) 1.78
Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. Virology (1998) 1.73
The transmissible gastroenteritis coronavirus contains a spherical core shell consisting of M and N proteins. J Virol (1996) 1.69
Eukaryotic chaperonin CCT stabilizes actin and tubulin folding intermediates in open quasi-native conformations. EMBO J (2000) 1.67
Proteins induced in Bacillus subtilis infected with bacteriophage phi 29. Virology (1973) 1.67
Early virus protein synthesis in vaccinia virus-infected cells. J Gen Virol (1973) 1.63
Direct mapping of nuclear shell effects in the heaviest elements. Science (2012) 1.63
Interferon inhibits viral protein synthesis in L cells infected with vaccinia virus. Nature (1972) 1.63
Vaccinia virus membrane proteins p8 and p16 are cotranslationally inserted into the rough endoplasmic reticulum and retained in the intermediate compartment. J Virol (1997) 1.60
A 14K envelope protein of vaccinia virus with an important role in virus-host cell interactions is altered during virus persistence and determines the plaque size phenotype of the virus. Virology (1987) 1.59
Three-dimensional reconstruction of a recombinant influenza virus ribonucleoprotein particle. EMBO Rep (2001) 1.55
Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. Mol Cell Biol (1999) 1.54
Structural and functional characterization of a cell surface binding protein of vaccinia virus. J Biol Chem (1990) 1.54
Bacteriophage lambda preconnectors. Purification and structure. J Mol Biol (1984) 1.53
General morphology and capsid fine structure of African swine fever virus particles. Virology (1984) 1.52
Initial studies with high resolution TEM and electron energy loss spectroscopy studies of ferritin cores extracted from brains of patients with progressive supranuclear palsy and Alzheimer disease. Cell Mol Biol (Noisy-le-grand) (2000) 1.51
Purification and organization of the gene 1 portal protein required for phage P22 DNA packaging. Biochemistry (1988) 1.50
A conserved motif in S-layer proteins is involved in peptidoglycan binding in Thermus thermophilus. J Bacteriol (1996) 1.50
Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus. J Virol (1995) 1.47
Topology of the components of the DNA packaging machinery in the phage phi29 prohead. J Mol Biol (2000) 1.45
The 'sequential allosteric ring' mechanism in the eukaryotic chaperonin-assisted folding of actin and tubulin. EMBO J (2001) 1.41
Generation of a dominant 8-MDa deletion at the left terminus of vaccinia virus DNA. Proc Natl Acad Sci U S A (1985) 1.41
Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR. Mol Cell Biol (1996) 1.40
Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cell Immunol (1996) 1.38
A vaccinia virus core protein, p39, is membrane associated. J Virol (1996) 1.37
Characterization of a human astrovirus serotype 2 structural protein (VP26) that contains an epitope involved in virus neutralization. Virology (1994) 1.37
Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology (1997) 1.35
Bacteriophage T3 connector: three-dimensional structure and comparison with other viral head-tail connecting regions. J Mol Biol (1988) 1.34
Molecular cloning, encoding sequence, and expression of vaccinia virus nucleic acid-dependent nucleoside triphosphatase gene. Proc Natl Acad Sci U S A (1986) 1.31
Three-dimensional reconstruction of the connector of bacteriophage phi 29 at 1.8 nm resolution. J Mol Biol (1986) 1.31
Isolation and characterization of attenuated mutants of vaccinia virus. Virology (1987) 1.30
A suppressor of nonsense mutations in Bacillus subtilis. Eur J Biochem (1974) 1.30
The synthesis of encephalomyocarditis virus polypeptides in infected L-cells and cell-free systems. Eur J Biochem (1974) 1.28
The capillarity of nanometric water menisci confined inside closed-geometry viral cages. Proc Natl Acad Sci U S A (2009) 1.27
The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. Virology (1997) 1.26
Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence. J Virol (1987) 1.25
Overproduction and purification of the connector protein of Bacillus subtilis phage phi 29. Nucleic Acids Res (1984) 1.25
Studies on the mechanism of entry of vaccinia virus in animal cells. Arch Virol (1987) 1.25
Assembly of Bacillus subtilis phage phi29. 1. Mutants in the cistrons coding for the structural proteins. Eur J Biochem (1977) 1.24
Membrane protein molecules of transmissible gastroenteritis coronavirus also expose the carboxy-terminal region on the external surface of the virion. J Virol (1995) 1.24
A precursor of the neck appendage protein of B. subtilis phage phi 29. FEBS Lett (1974) 1.23
Structure of vaccinia DNA: analysis of the viral genome by restriction endonucleases. Virology (1978) 1.23
Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector. J Virol (2000) 1.22
C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly. J Virol (2001) 1.22
The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals. J Virol (1991) 1.22
The bacteriophage phi29 head-tail connector imaged at high resolution with the atomic force microscope in buffer solution. EMBO J (1997) 1.21
Defective vaccinia virus particles in interferon-treated infected cells. Virology (1984) 1.21
Structure of the head-tail connector of bacteriophage phi 29. J Mol Biol (1982) 1.21
Two types of virus-related particles are found during transmissible gastroenteritis virus morphogenesis. J Virol (1998) 1.21
Inducible expression of the vaccinia virus A17L gene provides a synchronized system to monitor sorting of viral proteins during morphogenesis. J Virol (1996) 1.20
3D reconstruction of the ATP-bound form of CCT reveals the asymmetric folding conformation of a type II chaperonin. Nat Struct Biol (1999) 1.19
Structural and functional properties of the 14-kDa envelope protein of vaccinia virus synthesized in Escherichia coli. J Biol Chem (1990) 1.18
Identification of functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus. J Virol (1999) 1.17
The interferon-induced double-stranded RNA-activated human p68 protein kinase inhibits the replication of vaccinia virus. Virology (1993) 1.16
Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi. Arch Biochem Biophys (1993) 1.16
Determination of surface topography of biological specimens at high resolution by scanning tunnelling microscopy. Nature (1985) 1.16
Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice. Proc Natl Acad Sci U S A (1998) 1.16
The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors. Oncogene (2000) 1.15
Replication of vaccinia DNA in mouse L cells. I. In vivo DNA synthesis. Virology (1977) 1.14
Different architectures in the assembly of infectious bursal disease virus capsid proteins expressed in insect cells. Virology (2000) 1.14
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses. Proc Natl Acad Sci U S A (1989) 1.14
Computer graphic display method for visualizing three-dimensional biological structures. Science (1986) 1.14
Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology (1997) 1.14
A protein similar to Escherichia coli gro EL is present in Bacillus subtilis. J Mol Biol (1982) 1.13
Structural maturation of the transmissible gastroenteritis coronavirus. J Virol (1999) 1.13
Crystallographic analysis reveals the 12-fold symmetry of the bacteriophage phi29 connector particle. J Mol Biol (1998) 1.13